Pyruvate Kinase Activity and Isozyme Composition in Normal Fibrous Tissue and Fibroblastic Proliferations
Overview
Affiliations
Pyruvate kinase (PK) was studied in 57 fibroblastic and fibrohistiocytic proliferations and normal fibrous tissue (n = 10). The specific activity was significantly increased in malignant tumors (1.67 +/- 0.25) compared with normal tissue (0.26 +/- 0.04; P less than 0.001) and benign proliferations (0.52 +/- 0.05; P less than 0.005). Although an overlap exists between aggressive fibromatosis and the benign group, high values of PK activity are indicative of Grade 2 and 3 malignancy. Significant shifts in isozyme pattern, favoring the expression of K-type subunits were found in tumors with a metastasizing potential and aggressive fibromatosis. These changes in the isozyme pattern of PK in aggressive fibromatosis may act as another argument to place them in the category of malignant fibroblastic tumors.
Huang Y, Li B, Gui Z, Gao E, Yuan Y, Yang J Int J Mol Sci. 2025; 25(24.
PMID: 39769010 PMC: 11675365. DOI: 10.3390/ijms252413246.
Extracellular PKM2 facilitates organ-tissue fibrosis progression.
Han H, Zhang Y, Peng G, Li L, Yang J, Yuan Y iScience. 2021; 24(10):103165.
PMID: 34693222 PMC: 8517170. DOI: 10.1016/j.isci.2021.103165.
Li L, Peng G, Liu X, Zhang Y, Han H, Liu Z iScience. 2020; 23(11):101684.
PMID: 33196019 PMC: 7644948. DOI: 10.1016/j.isci.2020.101684.
Pyruvate kinase M2: A simple molecule with complex functions.
AlQuraishi M, Puckett D, Alani D, Humidat A, Frankel V, Donohoe D Free Radic Biol Med. 2019; 143:176-192.
PMID: 31401304 PMC: 6848794. DOI: 10.1016/j.freeradbiomed.2019.08.007.
A critical review of the role of MPYK in the Warburg effect.
Harris R, Fenton A Biochim Biophys Acta Rev Cancer. 2019; 1871(2):225-239.
PMID: 30708038 PMC: 6525063. DOI: 10.1016/j.bbcan.2019.01.004.